Structural studies of vacuolar plasmepsins

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1824, Issue 1, 2012, Pages 207-223

  Bhaumik, Prasenjit ^a   Gustchina, Alla ^a   Wlodawer, Alexander ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aspartic protease; Crystal structure; Inhibitors; Malaria; Plasmepsin

Indexed keywords

ANTIMALARIAL AGENT; ASPARTIC PROTEINASE; CHLOROQUINE; DIMER; HEMOGLOBIN; LIGAND; OLIGOMER; PEPSINOGEN; PEPSTATIN; PLASMEPSIN I; PLASMEPSIN II; PYRIMETHAMINE PLUS SULFADOXINE;

AMINO ACID SEQUENCE; BINDING AFFINITY; CATALYSIS; CRYSTAL STRUCTURE; ENZYME INHIBITION; ENZYME STRUCTURE; GENOME; MALARIA; MOLECULE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEASE INHIBITORS; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP; VACUOLES;

PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX;

EID: 82755161768     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2011.04.008     Document Type: Review

References (83)

1. B.M. Greenwood, K. Bojang, C.J. Whitty, and G.A. Targett Malaria Lancet 365 2005 1487 1498 (Pubitemid 40591695)
2. R. Banerjee, J. Liu, W. Beatty, L. Pelosof, M. Klemba, and D.E. Goldberg Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine Proc. Natl. Acad. Sci. U. S. A. 99 2002 990 995 (Pubitemid 34106623)
3. Y.L. Fong, F.C. Cadigan, and G.R. Coatney A presumptive case of naturally occurring Plasmodium knowlesi malaria in man in Malaysia Trans. R. Soc. Trop. Med. Hyg. 65 1971 839 840
4. K. Ersmark, B. Samuelsson, and A. Hallberg Plasmepsins as potential targets for new antimalarial therapy Med. Res. Rev. 26 2006 626 666 (Pubitemid 44230415)
5. P.G. Kremsner, and S. Krishna Antimalarial combinations Lancet 364 2004 285 294
6. S.E. Francis, D.J. Sullivan Jr., and D.E. Goldberg Hemoglobin metabolism in the malaria parasite Plasmodium falciparum Annu. Rev. Microbiol. 51 1997 97 123 (Pubitemid 27433044)
7. J. Liu, I.Y. Gluzman, M.E. Drew, and D.E. Goldberg The role of Plasmodium falciparum food vacuole plasmepsins J. Biol. Chem. 280 2005 1432 1437
8. 14C-amino- acids by malaria (plasmodium lophurae) IV. In vivo utilization of host cell haemoglobin Int. J. Biochem. 1 1970 635 637
9. A. Esposito, T. Tiffert, J.M. Mauritz, S. Schlachter, L.H. Bannister, C.F. Kaminski, and V.L. Lew FRET imaging of hemoglobin concentration in Plasmodium falciparum-infected red cells PLoS One 3 2008 e3780
10. G.H. Coombs, D.E. Goldberg, M. Klemba, C. Berry, J. Kay, and J.C. Mottram Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets Trends Parasitol. 17 2001 532 537 (Pubitemid 34185360)
11. S.E. Francis, I.Y. Gluzman, A. Oksman, A. Knickerbocker, R. Mueller, M.L. Bryant, D.R. Sherman, D.G. Russell, and D.E. Goldberg Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase EMBO J. 13 1994 306 317 (Pubitemid 24034212)
12. J. Hill, L. Tyas, L.H. Phylip, J. Kay, B.M. Dunn, and C. Berry High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparum FEBS Lett. 352 1994 155 158 (Pubitemid 24298408)
13. I. Russo, S. Babbitt, V. Muralidharan, T. Butler, A. Oksman, and D.E. Goldberg Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte Nature 463 2010 632 636
14. J.A. Boddey, A.N. Hodder, S. Gunther, P.R. Gilson, H. Patsiouras, E.A. Kapp, J.A. Pearce, T.F. Koning-Ward, R.J. Simpson, B.S. Crabb, and A.F. Cowman An aspartyl protease directs malaria effector proteins to the host cell Nature 463 2010 627 631
15. P. Bhaumik, H. Xiao, C.L. Parr, Y. Kiso, A. Gustchina, R.Y. Yada, and A. Wlodawer Crystal structures of the histo-aspartic protease (HAP) from Plasmodium falciparum J. Mol. Biol. 388 2009 520 540
16. C.D. Carroll, H. Patel, T.O. Johnson, T. Guo, M. Orlowski, Z.M. He, C.L. Cavallaro, J. Guo, A. Oksman, I.Y. Gluzman, J. Connelly, D. Chelsky, D.E. Goldberg, and R.E. Dolle Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library Bioorg. Med. Chem. Lett. 8 1998 2315 2320 (Pubitemid 28551489)
17. P.O. Johansson, Y. Chen, A.K. Belfrage, M.J. Blackman, I. Kvarnstrom, K. Jansson, L. Vrang, E. Hamelink, A. Hallberg, A. Rosenquist, and B. Samuelsson Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs J. Med. Chem. 47 2004 3353 3366 (Pubitemid 38746087)
18. K. Hidaka, T. Kimura, A.J. Ruben, T. Uemura, M. Kamiya, A. Kiso, T. Okamoto, Y. Tsuchiya, Y. Hayashi, E. Freire, and Y. Kiso Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin Bioorg. Med. Chem. 16 2008 10049 10060
19. T. Miura, K. Hidaka, T. Uemura, K. Kashimoto, Y. Hori, Y. Kawasaki, A.J. Ruben, E. Freire, T. Kimura, and Y. Kiso Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution Bioorg. Med. Chem. Lett. 20 2010 4836 4839
20. P.A. Moura, J.B. Dame, and D.A. Fidock Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors Antimicrob. Agents Chemother. 53 2009 4968 4978
21. D.R. Davies The structure and function of the aspartic proteinases Annu. Rev. Biophys. Biophys. Chem. 19 1990 189 215 (Pubitemid 20205623)
22. B.M. Dunn Structure and mechanism of the pepsin-like family of aspartic peptidases Chem. Rev. 102 2002 4431 4458
23. N.S. Andreeva, and L.D. Rumsh Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes Protein Sci. 10 2001 2439 2450 (Pubitemid 33091567)
24. T.L. Blundell The Aspartic Proteinases-an Historical Overview M.N.G. James, The Aspartic Proteinases 1998 Plenum Press 1 13
25. K. Suguna, R. Bott, E. Padlan, E. Subramanian, S. Sheriff, G. Cohen, and D. Davies Structure and refinement at 1.8 Å resolution of the aspartic proteinase from Rhizopus chinensis J. Mol. Biol. 196 1987 877 900
26. L. Coates, H.F. Tuan, S. Tomanicek, A. Kovalevsky, M. Mustyakimov, P. Erskine, and J. Cooper The catalytic mechanism of an aspartic proteinase explored with neutron and X-ray diffraction J. Am. Chem. Soc. 130 2008 7235 7237 (Pubitemid 351813210)
27. K. Suguna, E.A. Padlan, C.W. Smith, W.D. Carlson, and D.R. Davies Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action Proc. Natl. Acad. Sci. U. S. A. 84 1987 7009 7013
28. O.A. Asojo, E. Afonina, S.V. Gulnik, B. Yu, J.W. Erickson, R. Randad, D. Medjahed, and A.M. Silva Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 Å in complex with the inhibitors rs367 and rs370 Acta Crystallogr. D58 2002 2001 2008 (Pubitemid 35450821)
29. O.A. Asojo, S.V. Gulnik, E. Afonina, B. Yu, J.A. Ellman, T.S. Haque, and A.M. Silva Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum J. Mol. Biol. 327 2003 173 181 (Pubitemid 36293310)
30. D. Gupta, R.S. Yedidi, S. Varghese, L.C. Kovari, and P.M. Woster Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents J. Med. Chem. 53 2010 4234 4247
31. S. Bjelic, and J. Aqvist Computational prediction of structure, substrate binding mode, mechanism, and rate for a malaria protease with a novel type of active site Biochemistry 43 2004 14521 14528 (Pubitemid 39524927)
32. N. Andreeva, P. Bogdanovich, I. Kashparov, M. Popov, and M. Stengach Is histoaspartic protease a serine protease with a pepsin-like fold? Proteins 55 2004 705 710 (Pubitemid 38620093)
33. J.B. Dame, C.A. Yowell, L. Omara-Opyene, J.M. Carlton, R.A. Cooper, and T. Li Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man Mol. Biochem. Parasitol. 130 2003 1 12 (Pubitemid 37205156)
34. A.R. Khan, and M.N.G. James Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes Protein Sci. 7 1998 815 836 (Pubitemid 28216525)
35. N.K. Bernstein, M.M. Cherney, H. Loetscher, R.G. Ridley, and M.N. James Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from Plasmodium falciparum Nat. Struct. Biol. 6 1999 32 37 (Pubitemid 29232421)
36. S.E. Francis, R. Banerjee, and D.E. Goldberg Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II J. Biol. Chem. 272 1997 14961 14968 (Pubitemid 27251770)
37. H. Xiao, A.F. Sinkovits, B.C. Bryksa, M. Ogawa, and R.Y. Yada Recombinant expression and partial characterization of an active soluble histo-aspartic protease from Plasmodium falciparum Protein Expr. Purif. 49 2006 88 94 (Pubitemid 44278626)
38. J.C. Clemente, L. Govindasamy, A. Madabushi, S.Z. Fisher, R.E. Moose, C.A. Yowell, K. Hidaka, T. Kimura, Y. Hayashi, Y. Kiso, M. Agbandje-McKenna, J.B. Dame, B.M. Dunn, and R. McKenna Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor Acta Crystallogr. D62 2006 246 252 (Pubitemid 44185133)
39. A.M. Silva, A.Y. Lee, S.V. Gulnik, P. Maier, J. Collins, T.N. Bhat, P.J. Collins, R.E. Cachau, K.E. Luker, I.Y. Gluzman, S.E. Francis, A. Oksman, D.E. Goldberg, and J.W. Erickson Structure and inhibition of plasmepsin II, a hemoglobin- degrading enzyme from Plasmodium falciparum Proc. Natl. Acad. Sci. U. S. A. 93 1996 10034 10039 (Pubitemid 26314569)
40. N.K. Bernstein, M.M. Cherney, C.A. Yowell, J.B. Dame, and M.N. James Structural insights into the activation of P. vivax plasmepsin J. Mol. Biol. 329 2003 505 524 (Pubitemid 36593209)
41. A. Nezami, T. Kimura, K. Hidaka, A. Kiso, J. Liu, Y. Kiso, D.E. Goldberg, and E. Freire High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor Biochemistry 42 2003 8459 8464 (Pubitemid 36875411)
42. R.P. Moon, L. Tyas, U. Certa, K. Rupp, D. Bur, C. Jacquet, H. Matile, H. Loetscher, F. Grueninger-Leitch, J. Kay, B.M. Dunn, C. Berry, and R.G. Ridley Expression and characterisation of plasmepsin I from Plasmodium falciparum Eur. J. Biochem. 244 1997 552 560 (Pubitemid 27110759)
43. K.E. Luker, S.E. Francis, I.Y. Gluzman, and D.E. Goldberg Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole Mol. Biochem. Parasitol. 79 1996 71 78 (Pubitemid 26241906)
44. P. Bhaumik, Y. Horimoto, H. Xiao, T. Miura, K. Hidaka, Y. Kiso, A. Wlodawer, R.Y. Yada, and A. Gustchina Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum J. Struct. Biol. 175 2011 73 84
45. H. Xiao, T. Tanaka, M. Ogawa, and R.Y. Yada Expression and enzymatic characterization of the soluble recombinant plasmepsin I from Plasmodium falciparum Protein Eng. Des. Sel. 20 2007 625 633
46. N.S. Andreeva, A. Zdanov, A.E. Gustchina, and A.A. Fedorov Structure of ethanol-inhibited porcine pepsin at 2 Å resolution and binding of the methyl ester of phenylalanyl-diiodotyrosine to the enzyme J. Biol. Chem. 259 1984 11353 11366
47. P.T. Erskine, L. Coates, S. Mall, R.S. Gill, S.P. Wood, D.A. Myles, and J.B. Cooper Atomic resolution analysis of the catalytic site of an aspartic proteinase and an unexpected mode of binding by short peptides Protein Sci. 12 2003 1741 1749 (Pubitemid 36910053)
48. G.L. Gilliland, E.L. Winborne, J. Nachman, and A. Wlodawer The three-dimensional structure of recombinant bovine chymosin at 2.3 Å resolution Proteins 8 1990 82 101 (Pubitemid 20235333)
49. S.I. Foundling, J. Cooper, F.E. Watson, A. Cleasby, L.H. Pearl, B.L. Sibanda, A. Hemmings, S.P. Wood, T.L. Blundell, and M.J. Valler High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes Nature 327 1987 349 352 (Pubitemid 17075094)
50. E.T. Baldwin, T.N. Bhat, S. Gulnik, M.V. Hosur, R.C. Sowder II, R.E. Cachau, J. Collins, A.M. Silva, and J.W. Erickson Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design Proc. Natl. Acad. Sci. U. S. A. 90 1993 6796 6800 (Pubitemid 23207300)
51. L. Prade, A.F. Jones, C. Boss, S. Richard-Bildstein, S. Meyer, C. Binkert, and D. Bur X-ray structure of plasmepsin II complexed with a potent achiral inhibitor J. Biol. Chem. 280 2005 23837 23843 (Pubitemid 40884870)
52. J. Liu, E.S. Istvan, and D.E. Goldberg Hemoglobin-degrading plasmepsin II is active as a monomer J. Biol. Chem. 281 2006 38682 38688 (Pubitemid 46041994)
53. H. Xiao, L.A. Briere, S.D. Dunn, and R.Y. Yada Characterization of the monomer-dimer equilibrium of recombinant histo-aspartic protease from Plasmodium falciparum Mol. Biochem. Parasitol. 173 2010 17 24
54. H. Remaut, C. Bompard-Gilles, C. Goffin, J.M. Frere, and J. Van Beeumen Structure of the Bacillus subtilis D-aminopeptidase DppA reveals a novel self-compartmentalizing protease Nat. Struct. Biol. 8 2001 674 678 (Pubitemid 32757925)
55. G. Koelsch, M. Mares, P. Metcalf, and M. Fusek Multiple functions of pro-parts of aspartic proteinase zymogens FEBS Lett. 343 1994 6 10 (Pubitemid 24123936)
56. R. Banerjee, S.E. Francis, and D.E. Goldberg Food vacuole plasmepsins are processed at a conserved site by an acidic convertase activity in Plasmodium falciparum Mol. Biochem. Parasitol. 129 2003 157 165 (Pubitemid 36794568)
57. C.L. Parr, T. Tanaka, H. Xiao, and R.Y. Yada The catalytic significance of the proposed active site residues in Plasmodium falciparum histoaspartic protease FEBS J. 275 2008 1698 1707 (Pubitemid 351463988)
58. P. Liu, M.R. Marzahn, A.H. Robbins, H. Gutierrez-de-Teran, D. Rodriguez, S.H. McClung, S.M. Stevens Jr., C.A. Yowell, J.B. Dame, R. McKenna, and B.M. Dunn Recombinant plasmepsin 1 from the human malaria parasite Plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis Biochemistry 48 2009 4086 4099
59. M.N.G. James, and A.R. Sielecki Molecular structure of an aspartic proteinase zymogen, porcine pepsinogen, at 1.8 Å resolution Nature 319 1986 33 38 (Pubitemid 16189826)
60. S.A. Moore, A.R. Sielecki, M.M. Chernaia, N.I. Tarasova, and M.N.G. James Crystal and molecular structures of human progastricsin at 1.62 Å resolution J. Mol. Biol. 247 1995 466 485
61. A.R. Sielecki, M. Fujinaga, R.J. Read, and M.N. James Refined structure of porcine pepsinogen at 1.8 Å resolution J. Mol. Biol. 219 1991 671 692 (Pubitemid 121003542)
62. N.S. Andreeva, and A.E. Gustchina On the supersecondary structure of acid proteases Biochem. Biophys. Res. Commun. 87 1979 32 42
63. L. Pearl, and T. Blundell The active site of aspartic proteinases FEBS Lett. 174 1984 96 101
64. A.H. Robbins, B.M. Dunn, M. Agbandje-McKenna, and R. McKenna Crystallographic evidence for noncoplanar catalytic aspartic acids in plasmepsin II resides in the Protein Data Bank Acta Crystallogr. D65 2009 294 296
65. K. Suguna, E.A. Padlan, R. Bott, J. Boger, K.D. Parris, and D.R. Davies Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors Proteins 13 1992 195 205
66. I. Schechter, and A. Berger On the size of the active site in proteases. I. Papain Biochem. Biophys. Res. Commun. 27 1967 157 162
67. R. Friedman, and A. Caflisch The protonation state of the catalytic aspartates in plasmepsin II FEBS Lett. 581 2007 4120 4124 (Pubitemid 47212108)
68. H. Maegawa, T. Kimura, Y. Arii, Y. Matsui, S. Kasai, Y. Hayashi, and Y. Kiso Identification of peptidomimetic HTLV-I protease inhibitors containing hydroxymethylcarbonyl (HMC) isostere as the transition-state mimic Bioorg. Med. Chem. Lett. 14 2004 5925 5929 (Pubitemid 39421545)
69. A. Nezami, I. Luque, T. Kimura, Y. Kiso, and E. Freire Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target Biochemistry 41 2002 2273 2280 (Pubitemid 34160888)
70. I.Y. Gluzman, S.E. Francis, A. Oksman, C.E. Smith, K.L. Duffin, and D.E. Goldberg Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway J. Clin. Invest. 93 1994 1602 1608 (Pubitemid 24116398)
71. M. Zurcher, T. Gottschalk, S. Meyer, D. Bur, and F. Diederich Exploring the flap pocket of the antimalarial target plasmepsin II: the "55% rule" applied to enzymes ChemMedChem 3 2008 237 240
72. C. Oefner, A. Binggeli, V. Breu, D. Bur, J.P. Clozel, A. D'Arcy, A. Dorn, W. Fischli, F. Gruninger, R. Guller, G. Hirth, H. Marki, S. Mathews, M. ller, R.G. Ridley, H. Stadler, E. Vieira, M. Wilhelm, F. Winkler, and W. Wostl Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases? Chem. Biol. 6 1999 127 131 (Pubitemid 29363148)
73. A. Nezami, and E. Freire The integration of genomic and structural information in the development of high affinity plasmepsin inhibitors Int. J. Parasitol. 32 2002 1669 1676 (Pubitemid 35336008)
74. H.M. Abdel-Rahman, T. Kimura, K. Hidaka, A. Kiso, A. Nezami, E. Freire, Y. Hayashi, and Y. Kiso Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases Biol. Chem. 385 2004 1035 1039 (Pubitemid 39600311)
75. A. Kiso, K. Hidaka, T. Kimura, Y. Hayashi, A. Nezami, E. Freire, and Y. Kiso Search for substrate-based inhibitors fitting the S2′ space of malarial aspartic protease plasmepsin II J. Pept. Sci. 10 2004 641 647 (Pubitemid 39504362)
76. H. Gutierrez-de-Teran, M. Nervall, K. Ersmark, P. Liu, L.K. Janka, B. Dunn, A. Hallberg, and J. Aqvist Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum Biochemistry 45 2006 10529 10541 (Pubitemid 44320469)
77. P.M.D. Fitzgerald, B.M. McKeever, J.F. VanMiddlesworth, J.P. Springer, J.C. Heimbach, C.-T. Leu, W.K. Herber, R.A.F. Dixon, and P.L. Darke Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0 Å resolution J. Biol. Chem. 265 1990 14209 14219
78. C. Boss, O. Corminboeuf, C. Grisostomi, S. Meyer, A.F. Jones, L. Prade, C. Binkert, W. Fischli, T. Weller, and D. Bur Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV ChemMedChem 1 2006 1341 1345
79. R. Bhargavi, G.M. Sastry, U.S. Murty, and G.N. Sastry Structural and active site analysis of plasmepsins of Plasmodium falciparum: potential anti-malarial targets Int. J. Biol. Macromol. 37 2005 73 84 (Pubitemid 41539677)
80. C. Binkert, M. Frigerio, A. Jones, S. Meyer, C. Pesenti, L. Prade, F. Viani, and M. Zanda Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases Chembiochem 7 2006 181 186 (Pubitemid 43076302)
81. P.O. Johansson, J. Lindberg, M.J. Blackman, I. Kvarnstrom, L. Vrang, E. Hamelink, A. Hallberg, A. Rosenquist, and B. Samuelsson Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II J. Med. Chem. 48 2005 4400 4409 (Pubitemid 40884942)
82. J.D. Thompson, D.G. Higgins, and T.J. Gibson CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res. 22 1994 4673 4680 (Pubitemid 24354800)
83. P. Gouet, E. Courcelle, D.I. Stuart, and F. Metoz ESPript: analysis of multiple sequence alignments in PostScript Bioinformatics 15 1999 305 308 (Pubitemid 29213756)